1-4 of 4
Roman Crazzolara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients

Roman Crazzolara, MD, Julia Hutter, Josef Fritz, MD, Christina Salvador, MD, Cornelia Lass-Flörl, MD, Gabriele Kropshofer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3971.
https://doi.org/10.1182/blood-2018-99-110104
Published: 2018
Journal Articles

Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia

Roman Crazzolara, Adam Cisterne, Marilyn Thien, John Hewson, Rana Baraz, Kenneth F. Bradstock, Linda J. Bendall
Journal: Blood
Blood (2009) 113 (14): 3297–3306.
https://doi.org/10.1182/blood-2008-02-137752
Published: 2009
Includes: Supplemental data
Journal Articles

The mTOR Inhibitor RAD001 (Everolimus) Improves Survival in Preclinical Models of Primary Human ALL.

Roman Crazzolara, MD, Adam Cisterne, BSc, Marilyn Thien, Bsc, PhD, John Hewson, MD, Kenneth Francis Bradstock, MD, PhD, Linda J. Bendall, BSc, PhD
Journal: Blood
Blood (2007) 110 (11): 856.
https://doi.org/10.1182/blood.V110.11.856.856
Published: 2007
Journal Articles

Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia

Clinical Trials & Observations
Stefan Schmidt, Johannes Rainer, Stefan Riml, Christian Ploner, Simone Jesacher, Clemens Achmüller, Elisabeth Presul, Sergej Skvortsov, Roman Crazzolara, Michael Fiegl, Taneli Raivio, Olli A. Jänne, Stephan Geley, Bernhard Meister, Reinhard Kofler
Journal: Blood
Blood (2006) 107 (5): 2061–2069.
https://doi.org/10.1182/blood-2005-07-2853
Published: 2006
Includes: Supplemental data